Gilead’s Drug Leads Global Race for Coronavirus Treatment (1)

China will release results at the end of April from clinical trials of a Gilead Sciences Inc. drug that is emerging as a frontrunner in the race to find an effective treatment for the novel coronavirus.

The outcome of trials of the experimental medication remdesivir on 761 patients in Wuhan, the city where the virus originated, will be made public on April 27, China’s National Intellectual Property Administration said Tuesday.

The update on the trials’ progress came a day after the World Health Organization said that remdesivir may be the only effective treatment so far for the disease, which has ...